{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:17:31Z","timestamp":1788538651734,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010296","name":"Vignan's Foundation for Science, Technology and Research","doi-asserted-by":"publisher","award":["VFSTR\/REG\/A6\/30\/2023-24\/01"],"award-info":[{"award-number":["VFSTR\/REG\/A6\/30\/2023-24\/01"]}],"id":[{"id":"10.13039\/501100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025178","name":"OpenAI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025178","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006785","name":"Google","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jmgm.2026.109504","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:55:27Z","timestamp":1782888927000},"page":"109504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In Silico identification of natural and synthetic inhibitors targeting KRAS mutants (G12D, G12V, and G12C) and wild-type in pancreatic cancer"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3418-3374","authenticated-orcid":false,"given":"Hemantha Mani Kumar Chakravarthi","family":"Chanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-2141","authenticated-orcid":false,"given":"Sudheer Kumar","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109504_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194589","article-title":"Single cell RNA sequencing: a new frontier in pancreatic ductal adenocarcinoma","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109504_bib2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/biomedicines13071733","article-title":"Early detection of pancreatic cancer: current advances and future opportunities","volume":"13","author":"Lin","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmgm.2026.109504_bib3","article-title":"Unraveling pancreatic cancer: epidemiology, risk factors, and global trends","author":"Bin Qadir","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jmgm.2026.109504_bib4","first-page":"24100","article-title":"Mortality for pancreatic cancer throughout 2003\u20132022 in the US","volume":"7","author":"Camilla","year":"2024","journal-title":"J. Pancreatol"},{"key":"10.1016\/j.jmgm.2026.109504_bib5","doi-asserted-by":"crossref","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.jmgm.2026.109504_bib6","article-title":"Surgical and survival outcomes of neoadjuvant IMRT-based chemoradiotherapy versus upfront surgery in borderline resectable pancreatic cancer: a retrospective cohort study","volume":"16","author":"Huang","year":"2026","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109504_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221084853","article-title":"Predictive model of early death of resectable pancreatic ductal adenocarcinoma after curative resection: a SEER-based study","volume":"29","author":"Liu","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.jmgm.2026.109504_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-021-02674-x","article-title":"Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus","volume":"24","author":"Carrato","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jmgm.2026.109504_bib9","doi-asserted-by":"crossref","DOI":"10.21873\/cdp.10303","article-title":"FOLFIRINOX or gemcitabine plus nab-paclitaxel as first line treatment in pancreatic cancer: a real-world comparison","volume":"4","author":"Orlandi","year":"2024","journal-title":"Cancer Diagnosis and Prognosis"},{"key":"10.1016\/j.jmgm.2026.109504_bib10","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v14.i3.93869","article-title":"Interaction between tumor stage and age on survival outcomes of patients with anaplastic thyroid cancer","volume":"14","author":"Bangolo","year":"2024","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.jmgm.2026.109504_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jmgm.2026.109504_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08101-1","article-title":"Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming","volume":"16","author":"Tian","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmgm.2026.109504_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02473-8","article-title":"Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges","volume":"10","author":"Choucair","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jmgm.2026.109504_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jmgm.2026.109504_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-07004-x","article-title":"KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence","volume":"12","author":"Amintas","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DDDT.S559325","article-title":"Key considerations for targeting KRAS in pancreatic cancer: potential impact on the treatment paradigm","volume":"20","author":"Eslinger","year":"2026","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jmgm.2026.109504_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02225-w","article-title":"The path to the clinic: a comprehensive review on direct KRASG12C inhibitors","volume":"41","author":"Kwan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jmgm.2026.109504_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-025-06118-9","article-title":"Pan-cancer analysis to character the clinicopathological and genomic features of KRAS-Mutated patients in China","volume":"151","author":"Wu","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jmgm.2026.109504_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102175","article-title":"Targeted therapies in pancreatic cancer: a new era of precision medicine","volume":"12","author":"Li","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmgm.2026.109504_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030398","article-title":"KRAS as a modulator of the inflammatory tumor microenvironment: therapeutic implications","volume":"11","author":"Pereira","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jmgm.2026.109504_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1369136","article-title":"Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies","volume":"11","author":"Linehan","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.jmgm.2026.109504_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172803","article-title":"KRAS G12C inhibition in solid tumors: biological breakthroughs, clinical evidence, and open challenges","volume":"17","author":"Vitiello","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109504_bib23","article-title":"Multiple strategies to develop small molecular KRAS directly bound inhibitors","volume":"28","author":"Zhou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109504_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13725","article-title":"KRASG12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening","volume":"19","author":"Tapia Contreras","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jmgm.2026.109504_bib25","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-21-1331","article-title":"Expanding the reach of precision oncology by drugging all KRAS mutants","volume":"12","author":"Hofmann","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jmgm.2026.109504_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-026-03441-x","article-title":"Decoding the raf-mek-erk-rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities","author":"Waldron","year":"2026","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jmgm.2026.109504_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-022-00985-w","article-title":"KRAS is vulnerable to reversible switch-II pocket engagement in cells","volume":"18","author":"Vasta","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmgm.2026.109504_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51828-2","article-title":"RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade","volume":"15","author":"Nokin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109504_bib29","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8643","article-title":"Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: recent advancements provide hope","volume":"50","author":"Zhang","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib30","article-title":"The KRASG12D inhibitor MRTX1133 elucidates KRAS-Mediated oncogenesis","volume":"28","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmgm.2026.109504_bib31","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c01441","article-title":"RAS(ON) therapies on the horizon to address KRAS resistance: highlight on a phase III clinical candidate daraxonrasib (RMC-6236)","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109504_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-025-02015-x","article-title":"An assist from the chaperone","volume":"21","author":"Miura","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmgm.2026.109504_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68950-y","article-title":"KRAS(G12C)\u2013AMG 510 interaction dynamics revealed by all-atom molecular dynamics simulations","volume":"10","author":"Pantsar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-024-02526-3","article-title":"Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors","volume":"43","author":"Ghazi Vakili","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmgm.2026.109504_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.jmgm.2026.109504_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225599","article-title":"Oncogenic KRAS: signaling and drug resistance","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109504_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/21541248.2025.2505441","article-title":"The structure of KRASG12C bound to divarasib highlights features of potent switch-II pocket engagement","volume":"15","author":"Fernando","year":"2024","journal-title":"Small GTPases"},{"key":"10.1016\/j.jmgm.2026.109504_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jcc.27373","article-title":"Do electrostatic interactions make a difference in physics\u2010based AutoDock4 scoring function?","author":"Shaimardanov","year":"2024","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109504_bib39","article-title":"Algorithm selection for protein\u2013ligand docking: strategies and analysis on ACE","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib40","article-title":"In Silico target identification and drug discovery for 5-proFAR isomerase inhibitors in critical fungal pathogens","author":"Chanda","year":"2025","journal-title":"Chem. Prod. Process Model."},{"key":"10.1016\/j.jmgm.2026.109504_bib41","author":"Ali"},{"key":"10.1016\/j.jmgm.2026.109504_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00955-8","article-title":"Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jmgm.2026.109504_bib43","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12DInhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109504_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200188","article-title":"Speed vs accuracy: effect on ligand pose accuracy of varying box size and exhaustiveness in AutoDock vina","volume":"42","author":"Agarwal","year":"2023","journal-title":"Mol. Inf."},{"key":"10.1016\/j.jmgm.2026.109504_bib45","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109504_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402521","article-title":"Natural flavonoids as primary Amoebic Meningoencephalitis inhibitor: virtual screening, Molecular docking, MD simulation, MMPBSA, density functional theory, principal component, and gibbs free energy landscape analyses","volume":"22","author":"Saha","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jmgm.2026.109504_bib47","volume":"28","author":"Alamri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109504_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/10286020.2024.2343821","article-title":"Flavonoids as potential KRAS inhibitors: DFT, molecular docking, molecular dynamics simulation and ADMET analyses","volume":"26","author":"Prinsa","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.jmgm.2026.109504_bib49","series-title":"Artificial Intelligence: a Multidisciplinary Approach Towards Teaching and Learning","first-page":"26","article-title":"Artificial intelligence and bioinformatics: a powerful synergy for drug design and discovery","author":"Chanda","year":"2024"},{"key":"10.1016\/j.jmgm.2026.109504_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40203-025-00476-5","article-title":"Decoding gout pathogenesis: target discovery and drug design through computational models","volume":"13","author":"Chanda","year":"2025","journal-title":"Silico Pharmacol"},{"key":"10.1016\/j.jmgm.2026.109504_bib51","article-title":"In silico assessment of cyanobacterial alkaloids as probable medications against SARS-CoV-2","volume":"2","author":"Sen","year":"2026"},{"key":"10.1016\/j.jmgm.2026.109504_bib52","doi-asserted-by":"crossref","DOI":"10.2174\/0115701638445449260119153953","article-title":"Targeting TMPRSS2 for prostate cancer therapy: a multi-step computational approach for identifying novel inhibitors","author":"Chanda","year":"2026","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jmgm.2026.109504_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138330","article-title":"In silico anticancer activity of isoxazolidine and isoxazolines derivatives: DFT study, ADMET prediction, and molecular docking","volume":"1308","author":"Mellaoui","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2026.109504_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109504_bib55","article-title":"In-silico investigation on drug likeness, toxicity and molecular docking on lung cancer proteins of metabolites from Indigofera hochstetteri Baker methanol extract","volume":"1","author":"R","year":"2025"},{"key":"10.1016\/j.jmgm.2026.109504_bib56","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrestox.5c00033","article-title":"Machine learning for toxicity prediction using chemical structures: pillars for success in the real world","volume":"38","author":"Seal","year":"2025","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jmgm.2026.109504_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117098","article-title":"Prediction of chemical-induced acute toxicity using in vitro assay data and chemical structure","volume":"492","author":"Luo","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109504_bib58","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1038\/s41598-024-58599-2","article-title":"DFT\/TDDFT calculations of geometry optimization, electronic structure and spectral properties of clevudine and telbivudine for treatment of chronic hepatitis B","volume":"14","author":"Tegegn","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib59","unstructured":"M.M. Khalaf, H. Abd El-Lateef, A. Abdou, Structural, DFT, molecular docking and biological activity of new Albendazole\u2010Norfloxacin mixed\u2010ligand complexes: promising metal complexes for combating microbial resistance and inflammation, Chem. Biodivers. (n.d.) e202402646\u2013e202402646."},{"key":"10.1016\/j.jmgm.2026.109504_bib60","doi-asserted-by":"crossref","DOI":"10.35378\/gujs.834249","article-title":"A DFT\/TD-DFT study on the molecular structure absorption and Fluorescence Spectra of Gas\/Solution phases adenosine 5\u2019\u2013triphosphate molecule","volume":"35","author":"Ekincioglu","year":"2022","journal-title":"Gazi University Journal of Science"},{"key":"10.1016\/j.jmgm.2026.109504_bib61","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1038\/s41598-023-35933-8","article-title":"First-principles density functional theoretical study on the structures, reactivity and spectroscopic properties of (NH) and (OH) Tautomer's of 4-(methylsulfanyl)-3[(1Z)-1-(2-phenylhydrazinylidene) ethyl] quinoline-2(1H)-one","volume":"13","author":"Halim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109504_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2021.1965032","article-title":"In silico trials to design potent inhibitors against matrilysin (MMP-7)","volume":"40","author":"Katari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109504_bib63","doi-asserted-by":"crossref","DOI":"10.4103\/JCSR.JCSR_72_20","article-title":"Lipopolysaccharide","volume":"10","author":"Pasala","year":"2021","journal-title":"J. Clin. Sci. Res."},{"key":"10.1016\/j.jmgm.2026.109504_bib64","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1021\/acsomega.3c06313","article-title":"In silico insights into the arsenic binding mechanism deploying application of computational biology-based toolsets","volume":"9","author":"Ahmad","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jmgm.2026.109504_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202501333","article-title":"Computational framework as a way forward robust approach in predictive biodegradation and underlying toxic hazards assessment of environmental contaminants","volume":"10","author":"Singh","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2026.109504_bib66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/07391102.2020.1815584","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","volume":"40","author":"Shivanika","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109504_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/11779322221125605","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of phytochemicals isolated from Croton dichogamus against the HIV-1 reverse transcriptase","volume":"16","author":"Terefe","year":"2022","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.jmgm.2026.109504_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/pro.3923","article-title":"The Bio3D packages for structural bioinformatics","volume":"30","author":"Grant","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2026.109504_bib69","article-title":"Trajectory maps: molecular dynamics visualization and analysis","volume":"6","author":"Ko\u017ei\u0107","year":"2024","journal-title":"NAR Genom. Bioinf."},{"key":"10.1016\/j.jmgm.2026.109504_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-026-11563-w","article-title":"In silico discovery of natural and synthetic inhibitors targeting AKT1 in prostate cancer","author":"Chanda","year":"2026","journal-title":"Mol. Divers."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326002305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326002305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:38:26Z","timestamp":1788536306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326002305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"alternative-id":["S1093326326002305"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109504","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Silico identification of natural and synthetic inhibitors targeting KRAS mutants (G12D, G12V, and G12C) and wild-type in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109504"}}